{
    "id": "357fb20b-fdb4-58f9-e063-6394a90ae2a7",
    "indications": {
        "text": "eplerenone tablets aldosterone antagonist indicated : treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions ( 1.2 ) .",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "hypertension : 50 mg daily , inadequate response , increase 50 mg twice daily . higher dosages recommended . ( 2.2 ) patients : measure serum potassium starting eplerenone tablets periodically thereafter . ( 2.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "eplerenone tablets , 25 mg , yellowish red color diamond shaped biconvex film coated tablets , debossed `` e `` one side `` 25 `` side . supplied : unit dose packages 30 ( 3 x 10 ) ndc 60687-451-21",
    "adverseReactions": "patients : serum potassium > 5.5 meq/l initiation ( 4 ) creatinine clearance \u226430 ml/min ( 4 ) concomitant strong cyp3a inhibitors ( 4 , 7.1 ) treatment hypertension : type 2 diabetes microalbuminuria ( 4 ) serum creatinine > 2.0 mg/dl males , > 1.8 mg/dl females ( 4 ) creatinine clearance < 50 ml/min ( 4 ) concomitant potassium supplements potassium-sparing diuretics ( 4 )",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "EPLERENONE",
            "code": "6995V82D0B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31547"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        }
    ],
    "organization": "American Health Packaging",
    "name": "EPLERENONE",
    "effectiveTime": "20250519",
    "indications_original": "Eplerenone Tablets are an aldosterone antagonist indicated for: the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.2 ).",
    "contraindications_original": "Hypertension: 50 mg once daily, For inadequate response, increase to 50 mg twice daily. Higher dosages are not recommended. ( 2.2 ) For all patients: Measure serum potassium before starting Eplerenone Tablets and periodically thereafter. ( 2.3 )",
    "warningsAndPrecautions_original": "Eplerenone Tablets, 25 mg, are yellowish red color diamond shaped biconvex film coated tablets, debossed with \"E\" on one side and \"25\" on other side.\n                  Supplied as:\n  \nUnit dose packages of 30 (3 x 10) NDC 60687-451-21",
    "adverseReactions_original": "For all patients: Serum potassium >5.5 mEq/L at initiation ( 4 ) Creatinine clearance \u226430 mL/min ( 4 ) Concomitant use with strong CYP3A inhibitors ( 4 , 7.1 ) For the treatment of hypertension: Type 2 diabetes with microalbuminuria ( 4 ) Serum creatinine >2.0 mg/dL in males, >1.8 mg/dL in females ( 4 ) Creatinine clearance <50 mL/min ( 4 ) Concomitant use of potassium supplements or potassium-sparing diuretics ( 4 )",
    "drug": [
        {
            "name": "EPLERENONE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31547"
        }
    ]
}